Zinc inhibits TRPV1 to alleviate chemotherapy-induced neuropathic pain

  • Jialie Luo
  • , Alexis Bavencoffe
  • , Pu Yang
  • , Jing Feng
  • , Shijin Yin
  • , Aihua Qian
  • , Weihua Yu
  • , Shenbin Liu
  • , Xuan Gong
  • , Tao Cai
  • , Edgar T. Walters
  • , Carmen W. Dessauer
  • , Hongzhen Hu

Research output: Contribution to journalArticlepeer-review

67 Scopus citations

Abstract

Zinc is a transition metal that has a long history of use as an anti-inflammatory agent. It also soothes pain sensations in a number of animal models. However, the effects and mechanisms of zinc on chemotherapy-induced peripheral neuropathy remain unknown. Here we show that locally injected zinc markedly reduces neuropathic pain in male and female mice induced by paclitaxel, a chemotherapy drug, in a TRPV1-dependentmanner.Extracellularly applied zinc also inhibits the function ofTRPV1expressed inHEK293cellsandmouseDRGneurons, which requires thepresenceofzinc-permeableTRPA1tomediateentry of zinc into thecytoplasm.Moreover,TRPA1isrequiredforzinc-induced inhibition of TRPV1-mediated acute nociception. Unexpectedly, zinc transporters, but not TRPA1, are required for zinc-induced inhibition of TRPV1-dependent chronic neuropathic pain produced by paclitaxel. Together, our study demonstrates a novel mechanism underlying the analgesic effect of zinc on paclitaxel-induced neuropathic pain that relies on the function of TRPV1.

Original languageEnglish
Pages (from-to)474-483
Number of pages10
JournalJournal of Neuroscience
Volume38
Issue number2
DOIs
StatePublished - 10 Jan 2018
Externally publishedYes

Keywords

  • Neuropathic pain
  • Paclitaxel
  • TRPA1
  • TRPV1
  • Zinc

Fingerprint

Dive into the research topics of 'Zinc inhibits TRPV1 to alleviate chemotherapy-induced neuropathic pain'. Together they form a unique fingerprint.

Cite this